Mr. Judge is a mergers, acquisitions and securities lawyer with broad commercial, corporate governance and capital markets financing experience, both equity and debt, across multiple jurisdictions.
VANCOUVER, BC, September 19, 2023 /24-7PressRelease/ — Renaissance BioScience Corp., a leading global bioengineering company, is pleased to announce the appointment of Mr. Kenneth Judge to the Company’s Board of Directors. Mr. Judge was appointed a Strategic Advisor to the Renaissance Board in August 2023 and he will now be formally joining the Board as a Director.
Mr. Judge is a mergers, acquisitions and securities lawyer by background. He has broad commercial, corporate governance and capital markets financing experience, both equity and debt, across multiple jurisdictions and has held a significant number of public company chairmanships, and has acted as a chief executive, chief financial officer and as a non-executive Director of public companies listed on exchanges in Canada, the UK, Australia, Ireland and Peru.
“We’re pleased to welcome Ken to the Renaissance Board of Directors. He brings decades of Board, operations and advisory experience in multiple business disciplines and geographic environments globally and will be an active participant in building Renaissance. His transition from Board Advisor to Board member will be seamless and we look forward to working with him during this next phase of Renaissance corporate development. Renaissance is at a stage where Mr. Judge’s M&A and joint-venture experience will be very valuable and pertinent and his corporate governance experience will add to the governance foundation established by the current and previous Board members” said Maurice Boucher, Renaissance Co-Founder and Executive Chairman.
Mr. Judge comments: “I am delighted to be joining the Renaissance Board at this important moment in the company’s development and I look forward to helping to build upon the excellent work to date of the talented people on the Renaissance team.”
Renaissance wishes to thank Mr. Victor Dusik, who has stepped down from the Renaissance Board of Directors, where he has served since 2020, to pursue an important personal project. Vick’s contribution to Renaissance over the past three years, as Lead Director, Chair of the Audit Committee and a member of the Compensation Committee have been pivotal in setting the structural and policy foundation for the Board to implement the next phase of Renaissance corporate development.
About Renaissance BioScience Corp.
Renaissance is a leading bioengineering company based in Vancouver, British Columbia whose platform technologies are used to develop innovative, market-ready, functional microorganisms that provide cost effective solutions to a broad range of environmental, health and industrial efficiency problems. Renaissance technologies create products for multiple end-use industries, including food & beverage, agriculture crop protection, animal and human health and energy. Detailed information about the Renaissance group of companies can be accessed by visiting our website at www.renaissancebioscience.com.
For the original version of this press release, please visit 24-7PressRelease.com here